Madder, Robert
2 papers on CoChat
Most cited papers
- Verified
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
le Roux, C. W., Astrup, A., Fujioka, K., Greenway, F., Lau, D. C. W., Van Gaal, L., Ortiz, R. V., Wilding, J. P. H., Skjøth, T. V., Manning, L. S., et al. (2017) · The Lancet
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 850
- Verified · note
Repaglinide Versus Nateglinide Monotherapy
Rosenstock, J., Hassman, D. R., Madder, R. D., Brazinsky, S. A., Farrell, J., Khutoryansky, N., Hale, P. M., & for the Repaglinide Versus Nateglinide Comparison Study Group (2004) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 180
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free